Stoneridge (SRI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 sales reached $160.8 million, up 9.2% sequentially, driven by record MirrorEye sales, higher off-highway and Brazil OEM sales, and a strategic focus on technology-led growth and operational excellence.
MirrorEye sales set a new record at $33 million, up 11% from the prior quarter and 32% year-over-year, with over 150,000 systems produced globally.
Announced two major business awards totaling over $135 million in estimated lifetime revenue, including a new OEM-integrated MirrorEye program and a next-gen electronic controls program.
Outperformed weighted average OEM end markets by approximately 15% in Q1 2026, despite a 9.1% decline in those markets.
Sale of Control Devices segment completed January 30, 2026, with results presented as discontinued operations.
Financial highlights
Q1 2026 sales were $160.8 million, with adjusted gross margin expanding by 400 basis points to 21.7% and adjusted operating margin improving by 180 basis points sequentially.
Adjusted EBITDA reached $2.0 million (1.3% margin), exceeding break-even expectations.
Net loss for Q1 2026 was $27.0 million, including a $9.2 million loss on disposal of Control Devices; adjusted net loss was $20.9 million.
Stoneridge Brazil sales grew 9.4% sequentially to $18.1 million, with local OEM sales up 54% and adjusted operating income of $1.7 million (9.5% margin).
Net debt improved by $42.0 million to $85.9 million, aided by proceeds from the Control Devices sale.
Outlook and guidance
Full-year 2026 revenue guidance raised to $645–$670 million, reflecting $20 million incremental contract manufacturing revenue.
Adjusted operating margin guidance updated to breakeven to 0.5%, up 50 basis points from prior expectations.
Adjusted EBITDA guidance reaffirmed at $20–$25 million (3.1%–3.7% margin); adjusted gross margin guidance at 21.5%–22.0%.
Second quarter revenue expected to be slightly above Q1, with EBITDA improvement anticipated in the second half of the year.
Commitment to reduce structural costs by at least $5 million in 2026.
Latest events from Stoneridge
- Annual meeting covers director elections, auditor ratification, compensation, and ESG oversight.SRI
Proxy filing9 Apr 2026 - Annual meeting covers director elections, auditor ratification, and incentive plan amendment.SRI
Proxy filing9 Apr 2026 - 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025